Discover investment opportunities in Top 10 Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $3 using our Smart AI Filter.
5 stocks found for "Top 10 Stocks Under $3"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.19 | ±71.0% | -1.1 | 0.00% | |||
1.40 | ±59.3% | -45.5 | 0.00% | |||
0.44 | ±100.0% | -0.4 | 0.00% | |||
0.79 | ±46.9% | -62.2 | 0.00% | |||
1.19 | ±88.4% | -5.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
The FDA has notified Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia. The FDA has also signed off an additional Phase 3 trial focused on the long-term safety of brilaroxazine in patients with schizophrenia.
Read moreImmunic Inc (NASDAQ: IMUX) has executed an in-license agreement with the University Medical Center Goettingen covering the combination of DHODH inhibitors and nucleoside analogs to treat viral infections (COVID-19 and Influenza). The terms of the agreement were not disclosed.
Read moreQ: What should investors consider when evaluating the potential of stocks under $3, specifically looking at tickers like XAIR and DNN?
A: Stocks under $3, including XAIR and DNN, may offer high growth potential but can also be volatile. It’s essential to assess their market strategies, financial health, and industry trends. For example, XAIR in respiratory technologies and DNN in uranium mining have unique market dynamics that may affect their performance.
Q: How does the healthcare sector representation of RVPH and IMUX influence their stock performance under volatile market conditions?
A: RVPH and IMUX operate in the healthcare sector, which can be resilient during economic downturns due to ongoing demand for medical services. However, these stocks are priced under $3, indicating potential volatility and risk, often influenced by clinical trial results and regulatory approvals.
Q: What are mineral exploration opportunities related to the stock ticker WRN?
A: WRN is linked to the mining sector, focusing on properties in Western Canada. The sector’s appeal lies in the growing demand for minerals driven by technology and green energy trends. However, investors should account for regulatory and environmental challenges impacting the sector.
Q: How do energy sector trends affect the stock ticker HURA?
A: HURA is connected to the energy sector, particularly uranium, which benefits from renewable energy trends and nuclear energy adoption. While uranium demand may rise, the sector remains exposed to regulatory scrutiny and global energy policy changes, impacting stock performance.
Q: Are technological trends a significant aspect of OSTX’s business model?
A: OSTX operates within a tech-related field, and its future performance may align with broader technology trends such as AI, IoT, or cloud computing. Investors should examine OSTX's innovation capability and competitive positioning within these tech advancements.
Q: What risks might NASDAQ volatility pose for stocks like OKUR?
A: OKUR, being priced under $3 and listed on NASDAQ, may experience higher volatility due to market sentiment and macroeconomic trends affecting tech markets. Investors should be wary of potential rapid price swings and broader tech sector fluctuations.